Rivastigmine Tartrate 71209-0012-10
- Manufacturer
- Cadila Pharmaceuticals Limited
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- February 11, 2014
- Listing Expires
- December 31, 2026
- Application
- ANDA203844
Need to source Rivastigmine Tartrate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Rivastigmine Tartrate | 1.5 mg/1 |
Drug Class
Cholinesterase Inhibitor [EPC]Cholinesterase Inhibitors [MoA]
Selected Package
71209-0012-10Selected500 CAPSULE in 1 BOTTLE (71209-012-10)
Other packages for this product(1)
60 CAPSULE in 1 BOTTLE (71209-012-03)